Nissan Medical Industries Ltd

Tel Aviv Stock Exchange NISA.TA

Nissan Medical Industries Ltd Capital Expenditure for the year ending December 31, 2023: USD -2.80 M

Nissan Medical Industries Ltd Capital Expenditure is USD -2.80 M for the year ending December 31, 2023, a -1.79% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Nissan Medical Industries Ltd Capital Expenditure for the year ending December 31, 2022 was USD -2.75 M, a -3.11% change year over year.
  • Nissan Medical Industries Ltd Capital Expenditure for the year ending December 31, 2021 was USD -2.67 M, a 38.25% change year over year.
  • Nissan Medical Industries Ltd Capital Expenditure for the year ending December 31, 2020 was USD -4.33 M, a -46.67% change year over year.
  • Nissan Medical Industries Ltd Capital Expenditure for the year ending December 31, 2019 was USD -2.95 M, a 7.87% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
SV Wall Street
Tel Aviv Stock Exchange: NISA.TA

Nissan Medical Industries Ltd

CEO Mr. Yeheskel Nissan
IPO Date Feb. 1, 2000
Location Israel
Headquarters 11 Harogi Hamalkot Street
Employees 395
Sector Consumers Staples
Industries
Cleaning Supplies Baby & Childcare Composite Materials Consumer Packaged Goods Glass Leisure Personal Care Plastics
Description

Nissan Medical Industries Ltd, through its subsidiary, engages in the manufacturing and marketing of spunlace non-woven fabrics in the United States, Canada, Europe, and Israel. The company's products are used in reusable and consumable consumer products, medical products, automotive, infrastructure, hygienic, and other industries. It sells its products through its sales agents. Nissan Medical Industries Ltd was incorporated in 1984 and is based in Tel Aviv-Yafo, Israel.

StockViz Staff

February 5, 2025

Any question? Send us an email